Stacey M. Fernandes

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 30 papers. Top paper: “Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome”.

Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome

Nature Medicine(2023)10.1038/s41591-022-02113-6

N/A

1.7DataRank · unranked

83 citations

Ignaty Leshchiner, Romain Guièze, Connor Johnson, Eugen Tausch, Sameer A. Parikh +49 more

Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy

Blood Cancer Discovery(2020)10.1158/2643-3230.bcd-19-0058

N/A

0.946DataRank · unranked

30 citations

Anat Biran, Noelia Purroy, Camilla K. Lemvigh, Kendell Clement, Michaela Gruber +22 more

Molecular map of chronic lymphocytic leukemia and its impact on outcome

Nature Genetics(2022)10.1038/s41588-022-01140-w

N/A

0.753DataRank · unranked

150 citations

Ziao Lin, Cynthia K. Hahn, Ferran Nadeu, Martí Duran‐Ferrer, Kristen E. Stevenson +34 more

Activation of Notch and Myc Signaling via B-cell–Restricted Depletion of Dnmt3a Generates a Consistent Murine Model of Chronic Lymphocytic Leukemia

Cancer Research(2021)10.1158/0008-5472.can-21-1273

N/A

0.749DataRank · unranked

22 citations

Shanye Yin, Helene Kretzmer, Elisa Ten Hacken, Salma Parvin, Fabienne Lucas +26 more

Germline copy number variation associated with Mendelian inheritance of CLL in two families

Leukemia(2012)10.1038/leu.2012.33

N/A

0.627DataRank · unranked

11 citations

A Vartanov, M Ash, Christine A. Roden, Laura MacConaill, U Hainz +21 more

The role of the complement and contact systems in the dextran sulfate sodium-induced colitis model: the effect of C1 inhibitor in inflammatory bowel disease

American Journal of Physiology-Gastrointestinal and Liver Physiology(2010)10.1152/ajpgi.00400.2009

N/A

0.553DataRank · unranked

39 citations

Stacey M. Fernandes, Alvin E. Davis, Fengxin Lu

Functional Testing to Characterize and Stratify PI3K Inhibitor Responses in Chronic Lymphocytic Leukemia

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1221

N/A

0.385DataRank · unranked

12 citations

Paschalis Athanasiadis, Linda Karlsen, Aleksandra Urban, Haifeng Xu, Ishwarya Murali +12 more

1.11 Integrative Genomic Analysis Implicates PIK3CA and MYC in Chronic Lymphocytic Leukemia

Clinical Lymphoma Myeloma and Leukemia(2011)10.1016/j.clml.2011.09.012

N/A

0.133DataRank · unranked

1 citations

Megan Hanna, Bethany Tesar, Lillian Werner, Nathalie Pochet, John M. Asara +13 more

Risk Alleles Identified in Genome-Wide Association Studies Are Associated with Expression Quantitative Trait Loci in Chronic Lymphocytic Leukemia.

Blood(2012)10.1182/blood.v120.21.2875.2875

N/A

0.104DataRank · unranked

1 citations

Lillian Werner, Megan Hanna, Ma. Reina Improgo, Nathalie Pochet, Stacey M. Fernandes +8 more

Targeting constitutively active STAT3 in chronic lymphocytic leukemia: A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analyses

American Journal of Hematology(2020)10.1002/ajh.26084

N/A

0DataRank · unranked

29 citations

Sarah R. Walker, Lisa N. Heppler, Svitlana Tyekucheva, Erik A. Nelson, Josephine L. Klitgaard +15 more

A T cell inflammatory phenotype is associated with autoimmune toxicity of the PI3K inhibitor duvelisib in chronic lymphocytic leukemia

Leukemia(2021)10.1038/s41375-021-01441-9

N/A

0DataRank · unranked

21 citations

Alec Griffith, Svitlana Tyekucheva, Zixu Wang, Vanessa Rai, Alexander R. Vartanov +14 more

Supplementary Table 6 from Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia

INDIGO (University of Illinois at Chicago)(2023)10.1158/1078-0432.22444134.v1

N/A

0DataRank · unranked

0 citations

Megan Hanna, Bethany Tesar, Lillian Werner, Nathalie Pochet, John M. Asara +13 more

Post-Transformation IGHV-IGHD-IGHJ Mutations in Chronic Lymphocytic Leukemia B Cells: Implications for Mutational Mechanisms and Impact on Clinical Course

Frontiers in Oncology(2021)10.3389/fonc.2021.640731

N/A

0DataRank · unranked

16 citations

Catherine Tang, Jennifer R. Brown, Siddha Kasar, Stacey M. Fernandes, Monica Colombo +14 more

Multi-Factor Clustering Incorporating Cell Motility Predicts T Cell Expansion Potential

Frontiers in Cell and Developmental Biology(2021)10.3389/fcell.2021.648925

N/A

0DataRank · unranked

5 citations

Shuai Shao, Michelle Kim, Stacey M. Fernandes, Jennifer R. Brown, Lance C. Kam +1 more

Supplementary Table 6 from Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia

(2023)10.1158/1078-0432.22444134

N/A

0DataRank · unranked

0 citations

Megan Hanna, Bethany Tesar, Lillian Werner, Nathalie Pochet, John M. Asara +13 more

Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance

Blood Advances(2022)10.1182/bloodadvances.2022008447

N/A

0DataRank · unranked

80 citations

Filippo Utro, Qing Wang, Justin Cha, Mauno Vihinen, Stephen P. Martindale +20 more

Idelalisib reduces regulatory T cells and activates T helper 17 cell differentiation in relapsed refractory patients with chronic lymphocytic leukaemia

British Journal of Haematology(2022)10.1111/bjh.18053

N/A

0DataRank · unranked

15 citations

Alec Griffith, Zixu Wang, Svitlana Tyekucheva, Vanessa Rai, Stacey M. Fernandes +5 more

Data from Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia

(2023)10.1158/1078-0432.c.6520068

N/A

0DataRank · unranked

0 citations

Megan Hanna, Bethany Tesar, Lillian Werner, Nathalie Pochet, John M. Asara +13 more

Idelalisib activates AKT via increased recruitment of PI3Kδ/PI3Kβ to BCR signalosome while reducing PDK1 in post-therapy CLL cells

Leukemia(2022)10.1038/s41375-022-01595-0

N/A

0DataRank · unranked

5 citations

Hasan Mahmud, Guru Prasad Maiti, Mariana T. Mendez, Stacey M. Fernandes, Sara K. Vesely +4 more

Functional testing of PI3K inhibitors stratifies responders to idelalisib and identifies treatment vulnerabilities in idelalisib-refractory/intolerant chronic lymphocytic leukemia

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.04.14.488428

N/A

0DataRank · unranked

1 citations

Paschalis Athanasiadis, Linda Karlsen, Aleksandra Urban, Ishwarya Murali, Stacey M. Fernandes +11 more

Data from Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia

(2023)10.1158/1078-0432.c.6520068.v1

N/A

0DataRank · unranked

0 citations

Megan Hanna, Bethany Tesar, Lillian Werner, Nathalie Pochet, John M. Asara +13 more

METTL3-Mediated m6A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL

Blood Cancer Discovery(2023)10.1158/2643-3230.bcd-22-0156

N/A

0DataRank · unranked

28 citations

Meiling Jin, Mike M. Fernandez, Kevyn L. Hart, Aijun Liao, Xinzhou Ge +16 more

Circulating Th17 T cells at treatment onset predict autoimmune toxicity of PI3Kδ inhibitors

Blood Cancer Journal(2023)10.1038/s41408-023-00788-9

N/A

0DataRank · unranked

3 citations

Stephen P. Martindale, Pui Yan Chiu, Jasneet Kaur Khalsa, Pei-Hsuan Chen, Stacey M. Fernandes +10 more

Data from Activation of Notch and Myc Signaling via B-cell–Restricted Depletion of Dnmt3a Generates a Consistent Murine Model of Chronic Lymphocytic Leukemia

(2023)10.1158/0008-5472.c.6513540.v1

N/A

0DataRank · unranked

0 citations

Shanye Yin, Helene Kretzmer, Elisa Ten Hacken, Salma Parvin, Fabienne Lucas +26 more

Data from Functional Testing to Characterize and Stratify PI3K Inhibitor Responses in Chronic Lymphocytic Leukemia

(2023)10.1158/1078-0432.c.6532718

N/A

0DataRank · unranked

0 citations

Paschalis Athanasiadis, Linda Karlsen, Aleksandra Urban, Haifeng Xu, Ishwarya Murali +12 more

Data from Functional Testing to Characterize and Stratify PI3K Inhibitor Responses in Chronic Lymphocytic Leukemia

(2023)10.1158/1078-0432.c.6532718.v1

N/A

0DataRank · unranked

0 citations

Paschalis Athanasiadis, Linda Karlsen, Aleksandra Urban, Haifeng Xu, Ishwarya Murali +12 more

Investigating the influence of germline ATM variants in chronic lymphocytic leukemia on cancer vulnerability

Haematologica(2024)10.3324/haematol.2024.286031

N/A

0DataRank · unranked

3 citations

Francesca Morelli, Kiyomi Mashima, Rayan Fardoun, Svitlana Tyekucheva, Stacey M. Fernandes +7 more

Assaying and Classifying T Cell Function by Cell Morphology

BioMedInformatics(2024)10.3390/biomedinformatics4020063

N/A

0DataRank · unranked

2 citations

Stacey M. Fernandes, Jennifer R. Brown, Lance C. Kam, Xin Wang

Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia

Blood Advances(2025)10.1182/bloodadvances.2025016006

N/A

0DataRank · unranked

12 citations

Yinglu Zhou, Mariia Mikhaleva, Daniel Choi, Stacey M. Fernandes, Philippe Armand +20 more

Supplementary Methods, Figures 1-4 and Tables 1 - 5, 7 - 15 from Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia

INDIGO (University of Illinois at Chicago)(2023)10.1158/1078-0432.22444137.v1

N/A

0DataRank · unranked

0 citations

Megan Hanna, Bethany Tesar, Lillian Werner, Nathalie Pochet, John M. Asara +13 more